Carlsbad, CA 3/21/13—Active Motif, a provider of epigenetics-based research tools to analyze nuclear function, has acquired SwitchGear Genomics for an undisclosed amount. SwitchGear Genomics supplies research products for studying the human genome’s regulatory elements. “SwitchGear Genomics has a unique combination of expertise in computational regulatory element identification, experimental validation and data analysis that offers the […]
San Diego, CA 3/14/13; Tacoma, WA 3/14/12—A jury in the US District Court for the Western District of Washington at Tacoma has found that Illumina’s BeadChip array product infringes Syntrix Biosystems’ US Patent No. 6,951,682, entitled “Porous coatings bearing ligand arrays and use thereof” (see IBO 4/30/11). The jury ordered Illumina to pay Syntrix $96 […]
St. Louis, MO 3/22/13—The St. Louis Post-Dispatch has reported that Sigma-Aldrich plans to sell SAGE (Sigma Advanced Genetic Engineering) Labs, its research animal model business, to a private equity firm. A Sigma-Aldrich spokesperson told the newspaper that as the result of the company’s recent reorganization (see IBO 3/15/13), the business is not a strategic fit. […]
New York, NY 3/19/13; New York, NY 3/22/13—Reuters reported that Roche is contemplating a bid to acquire Life Technologies (see IBO 1/31/13, 2/28/13, 3/15/13), according to anonymous sources. However, Bloomberg later reported that Roche was only considering a purchase of part of the company. Two sources told Bloomberg that industry companies, such as Danaher or […]
Shenzhen, China, 3/15/13; Shenzhen, China, 3/12/13; Mountain View, CA, 3/12/13—BGI-Shenzhen’s wholly owned subsidiary Beta Acquisition Corporation has completed its all-cash tender offer for sequencing service provider Complete Genomics. BGI will purchase all outstanding shares of Complete Genomics common stock for $3.15 per share in cash without interest. Complete Genomics will become a wholly owned subsidiary […]
Sydney, Australia 1/24/13; Palo Alto, CA 3/4/13—Bioinformatics firm PREMIER Biosoft has acquired the assets of the ProteoIQ MS software business from NuSep for an undisclosed amount. The ProteoIQ platform provides proteomic data analysis to streamline the process of statistical validation, protein quantification and comparative proteomics. “For the rapidly growing proteomics market, ProteoIQ is a strategic […]
New York, NY 3/7/13—At its annual investors meeting, Agilent Technologies announced that it will exit its OEM and Specialty magnets business. The business, which it had acquired when it bought Varian (see IBO 7/31/09), makes super high-end magnets for research and other applications. Nick Roelofs, president of Agilent’s Life Sciences Group, told the conference, “This […]
New York, NY 3/5/13; New York, NY 3/6/13; New York, NY 3/12/13—Reuters reported on March 5 that private equity firms are interested in jointly making an offer to acquire Life Technologies (see IBO 1/31/13, 2/28/13), according to people familiar with the situation. The consortium would include Blackstone, Carlyle, TPG Capital and Temasek Holdings, but discussions […]
La Jolla, CA and Coralville, IA 2/27/13—Synthetic Genomics (SGI) has announced the formal launch of SGI-DNA for the development, manufacture and commercialization of its synthetic DNA technology. Synthetic Genomics and Integrated DNA Technologies (IDT) have also expanded their collaboration (see IBO 3/31/12) to include the manufacture and co-branding of cloned synthetic DNA constructs up to […]
Bologna, Italy 2/26/13; Sanford, ME 2/26/13—Filtration products manufacturer GVS has acquired a majority equity interest in Maine Manufacturing. The invested capital was used to support Maine Manufacturing’s recent acquisitions of selected GE Osmonics products (see IBO 12/15/12) and life science product lines from GE Healthcare (see IBO 1/15/13). “This alliance will allow Maine Manufacturing to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
